First off, I’d like to thank you for signing up for the ClassAction.org newsletter. We’ve been going through some changes here to try to make your experience with the site better than ever.
We are working on ways to get consumers like you more involved in our community. To start, we will be sending out two newsletters each month to highlight our current investigations into defective products, dangerous drugs and fraudulent business practices that may be affecting you or a loved one, as well as to provide updates on some of the year’s most pressing class action and mass tort lawsuits.
Be sure to check out our blog, as well as our current lawsuit list - and if you think you have a claim, or have a question, feel free to get in touch.
Testosterone therapies such as AndroGel and Axiron have been prescribed to tens of thousands of men as treatment for “low T.” Aside from reports that these products are being overprescribed due to potentially misleading marketing campaigns, two recent studies published in scientific journals have highlighted a worrying link between these treatments and cardiovascular events in men aged 65 and over and those with a history of heart problems. The first lawsuits have now been filed, seeking answers from the drug companies, as well as compensation for patients who suffered heart attacks and strokes while using low T products. Read More
You don’t expect a product marketed specifically as “flushable” to cause plumbing problems, blockages, and clogged pipes – but that may very well be exactly what’s happening. We’re currently investigating whether “flushable” wipes sold by companies such as Kleenex, Charmin, and Kirkland are, in fact, not flushable at all. Reports have surfaced that the wipes are damaging people’s homes when the products don’t break down, causing plumbing backups, low water pressure and other problems. Tests have shown that several brands of wipes fail to dissolve after a full ten minutes immersed in water. Read More
A class action lawsuit has been filed alleging that Goodman Manufacturing air conditioners, heat pumps and air handlers contain defective evaporator coils that can cause the units to fail. Owners of these Goodman products may be able to take legal action to recover compensation for the cost of repairing the broken units. It’s been suggested that Goodman actually knew about the defect but failed to warn buyers – even after a competitor changed the materials used in its production to overcome a similar problem. Read More
A lawsuit first filed in August of last year is making headlines after a Virginia federal judge approved class certification, paving the way for the suit to continue on behalf of thousands of same-sex couples living in the state. The suit’s aim is clear: to overturn and permanently prohibit the current laws banning same-sex partnerships. The ban was approved by 57% of Virginia voters in 2006, but a new poll reports that 56% now oppose the law. This all comes at a time when the federal government is moving to further expand benefit coverage for same-sex couples in all fifty states. Read More
The massive security breach at Target stores during Thanksgiving continues to raise important questions about how companies can help ensure their customers’ information is kept safe. Target’s now facing lawsuits from banks, as well as consumers angered over the company’s alleged lack of security. Read More
Johnson & Johnson is in trouble for destroying (or allowing to be destroyed) documents relating to the development and testing of its TVM products. In a recent move, though, the company argued that the documents’ destruction is irrelevant to lawsuits currently filed against it over TVM products, and claimed that the jury does not need to be told. Read More
Actos manufacturer Takeda has been slammed in court at the beginning of the first bellwether trial for destroying or losing key documents. The court called the breadth of lost files “disturbing” and is now allowing plaintiffs to present evidence of Takeda’s “bad faith,” while reserving the right to later impose sanctions. Read More
~ Forward to a friend ~
Know someone who might be interested in our newsletter? Why not forward this email to them?